Literature DB >> 1908455

Vasoactive intestinal peptide hydrolysis by antibody light chains.

S Mei1, B Mody, S H Eklund, S Paul.   

Abstract

This paper describes evidence for hydrolysis of a neuropeptide, vasoactive intestinal peptide (VIP), by light chains purified from the IgG of a human subject positive for VIP binding antibodies. Purified IgG was digested with papain, resultant fragment antigen binding (Fab) fragments were reduced with 2-mercaptoethanol and alkylated with iodoacetamide, and light chains were purified by chromatography on immobilized antibodies to light chains and immobilized antibodies to heavy chains. Non-immunoglobulin components were undetectable in the light chain preparation, judged by sodium dodecyl sulfate-electrophoresis and Western blotting with anti-heavy and anti-light chain antibodies. The light chains hydrolyzed VIP with specific activity 32-fold greater than that of Fab, the pH optimum for light chain-mediated VIP hydrolysis was 7.0-7.5, and the hydrolytic activity was saturable (Vmax, 0.19 pmol/min/microgram light chains; substrate concentration at Vmax/2,380 nM).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Natural catalytic antibodies.

Authors:  S Paul
Journal:  Mol Biotechnol       Date:  1996-06       Impact factor: 2.695

2.  Proteolytic components of serum IgG preparations.

Authors:  L Li; R Kalaga; S Paul
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

3.  An approach to sequence-specific antibody proteases. The use of haptens mimicking both a transition state and a distorted ground state.

Authors:  R M Smith; P Yuan; D P Weiner; C R Dutton; D E Hansen
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

4.  Amidolytic and peptidolytic activities of immunoglobulin G present in sera from patients with rheumatoid arthritis, Sjogren's syndrome and systemic lupus erythematosus.

Authors:  K Matsuura; S Ikoma; M Sugiyama; M Funauchi; H Sinohara
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

5.  Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.

Authors:  Hiroaki Taguchi; Stephanie Planque; Gopal Sapparapu; Stephane Boivin; Mariko Hara; Yasuhiro Nishiyama; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

6.  Physical activity and natural anti-VIP antibodies: potential role in breast and prostate cancer therapy.

Authors:  Milena Veljkovic; Violeta Dopsaj; Milivoj Dopsaj; Donald R Branch; Nevena Veljkovic; Maria M Sakarellos-Daitsiotis; Veljko Veljkovic; Sanja Glisic; Alfonso Colombatti
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  DNA-hydrolysing activity of IgG antibodies from the sera of patients with diseases caused by different bacterial infections.

Authors:  Taisiya A Parkhomenko; Elena S Odintsova; Valentina N Buneva; Elena V Kunder; Ivan V Zhyltsov; Sergey A Senkovich; Igor I Generalov; Georgy A Nevinsky
Journal:  J Cell Mol Med       Date:  2008-07-29       Impact factor: 5.310

Review 8.  Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans.

Authors:  Anna S Tolmacheva; Georgy A Nevinsky
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

9.  Biochemical features of a catalytic antibody light chain, 22F6, prepared from human lymphocytes.

Authors:  Emi Hifumi; Naoko Fujimoto; Mitsue Arakawa; Eri Saito; Shingo Matsumoto; Nobuyuki Kobayashi; Taizo Uda
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.